GO:0052871 alpha-tocopherol omega-hydroxylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0052871 (alpha-tocopherol omega-hydroxylase activity) catalyzes the omega-hydroxylation of alpha-tocopherol to 13-hydroxy-alpha-tocopherol, the first step in vitamin E catabolism [3,6].
• The enzyme is a cytochrome P450, primarily CYP4F2 in humans, that requires NADPH and a cytochrome P450 reductase for activity [3,5].
• This activity controls vitamin E status by regulating the breakdown of excess alpha-tocopherol, thereby preventing its accumulation [3,6].
• Substrate specificity is determined by structural features of tocopherols and tocotrienols, with alpha-tocopherol being a preferred substrate.
• Genetic variants in CYP4F2 alter enzyme activity and may influence vitamin E requirements and disease risk.
• Dysregulation of this pathway is implicated in nonalcoholic fatty liver disease and other metabolic disorders.
Description
Alpha-tocopherol omega-hydroxylase activity (GO:0052871) is a molecular function that initiates the catabolism of vitamin E. This enzymatic activity converts alpha-tocopherol to 13-hydroxy-alpha-tocopherol, a critical step in maintaining vitamin E homeostasis [3,6]. The reaction requires molecular oxygen and reduced NADPH-hemoprotein reductase, and is catalyzed by cytochrome P450 enzymes, notably CYP4F2 in humans [3,5]. Understanding this activity is essential for researchers studying vitamin E metabolism, as it directly influences the bioavailability and biological effects of this important antioxidant. The discovery of this pathway revealed that vitamin E levels are not solely determined by absorption and transport but are actively regulated through oxidative degradation. The enzyme's ability to discriminate among tocopherols and tocotrienols underscores its role in selective retention of alpha-tocopherol in tissues. Moreover, common polymorphisms in CYP4F2 that affect enzyme activity have been linked to altered vitamin E status, highlighting clinical relevance. Given the growing interest in vitamin E metabolites as signaling molecules and biomarkers, precise characterization of alpha-tocopherol omega-hydroxylase activity is crucial. This article provides a comprehensive overview of the enzyme's mechanism, key genes, regulatory aspects, and research methodologies, with a focus on CRISPR-based models for functional studies.
alpha-tocopherol omega-hydroxylase activity At A Glance
| GO ID | GO:0052871 |
|---|---|
| GO term | alpha-tocopherol omega-hydroxylase activity |
| Ontology | molecular_function |
| Synonym | alpha-tocopherol 13-hydroxylase activity |
| Major function | Catalyzes the omega-hydroxylation of alpha-tocopherol to 13-hydroxy-alpha-tocopherol, initiating vitamin E catabolism |
| Reaction | (+)-alpha-tocopherol + O2 + reduced [NADPH--hemoprotein reductase] = 13-hydroxy-alpha-tocopherol + H+ + H2O + oxidized [NADPH--hemoprotein reductase] |
| Cofactors | NADPH, cytochrome P450 reductase (NADPH--hemoprotein reductase) |
| Localization | Endoplasmic reticulum membrane (cytochrome P450 enzymes) |
| Enzyme class | Oxidoreductase, acting on paired donors with incorporation of molecular oxygen |
What Is GO:0052871?
Alpha-tocopherol omega-hydroxylase activity (GO:0052871) is defined as the catalysis of the reaction: (+)-alpha-tocopherol + O2 + reduced [NADPH--hemoprotein reductase] = 13-hydroxy-alpha-tocopherol + H+ + H2O + oxidized [NADPH--hemoprotein reductase]. In simpler terms, it is the enzyme activity that adds a hydroxyl group to the omega position of alpha-tocopherol, the first committed step in its breakdown. This activity is synonymous with alpha-tocopherol 13-hydroxylase activity and belongs to the molecular function ontology.
Why Is alpha-tocopherol omega-hydroxylase activity Important in Cell Biology?
Alpha-tocopherol omega-hydroxylase activity is critical for vitamin E homeostasis because it controls the rate-limiting step of alpha-tocopherol catabolism. By converting alpha-tocopherol to 13-hydroxy-alpha-tocopherol, this enzyme prevents excessive accumulation of the vitamin and generates metabolites with potential biological activities [3,6,8]. Dysregulation of this activity can lead to altered vitamin E status, which has implications for oxidative stress-related diseases, liver function, and neurological health [7,8].
• Regulates vitamin E status by controlling the catabolism of excess alpha-tocopherol [3,6].
• Determines the selective retention of alpha-tocopherol over other tocopherols in tissues.
• Genetic variants in CYP4F2 affect enzyme activity and may influence individual vitamin E requirements.
• Implicated in nonalcoholic fatty liver disease, where impaired activity leads to altered vitamin E metabolism.
• Generates 13-hydroxy-alpha-tocopherol, a metabolite that may have signaling functions.
• Plays a role in drug metabolism and potential interactions with vitamin E supplements [5,8].
• Provides a target for modulating vitamin E levels in disease prevention.
• Serves as a model for studying cytochrome P450-mediated omega-oxidation of lipophilic substrates.
• Its activity is conserved across species, from insects to humans, highlighting its fundamental importance.
• Understanding this activity aids in interpreting biomarkers of vitamin E intake and status.
What Happens During alpha-tocopherol omega-hydroxylase activity?
Substrate Binding and Recognition
In simple terms: The enzyme first grabs alpha-tocopherol and holds it in place.
The enzyme, a cytochrome P450, binds alpha-tocopherol in its active site. Structural features of the substrate, such as the phytyl tail and chromanol ring, determine specificity. Studies with various tocopherols and tocotrienols show that alpha-tocopherol is a preferred substrate, while other forms are less efficiently hydroxylated. This selectivity ensures that alpha-tocopherol, the most biologically active form of vitamin E, is preferentially catabolized when in excess.
Catalytic Cycle and Hydroxylation
In simple terms: The enzyme uses oxygen and electrons to add a hydroxyl group to the end of the vitamin E molecule.
The catalytic cycle involves the activation of molecular oxygen at the heme iron of the cytochrome P450, followed by insertion of one oxygen atom into the omega position of alpha-tocopherol. Electrons are supplied by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) [3,6]. The product is 13-hydroxy-alpha-tocopherol, which can undergo further oxidation to form alpha-tocopheronolactone and other metabolites.
Product Release and Further Metabolism
In simple terms: After the reaction, the modified vitamin E is released and can be broken down further.
The initial product, 13-hydroxy-alpha-tocopherol, is released from the enzyme and can be further metabolized by other enzymes to yield water-soluble metabolites such as alpha-carboxyethyl-6-hydroxychroman (alpha-CEHC). This step is crucial for the excretion of vitamin E and the generation of bioactive metabolites that may have anti-inflammatory or other effects.
Regulation of Enzyme Activity
In simple terms: The enzyme's activity can be turned up or down depending on the body's needs.
The activity of alpha-tocopherol omega-hydroxylase is regulated at multiple levels. Enzyme expression can be induced by vitamin E intake, and genetic polymorphisms in CYP4F2 affect specific activity. Additionally, conditions such as nonalcoholic fatty liver disease impair the cytochrome P450-dependent metabolism of alpha-tocopherol, leading to decreased activity. This regulation ensures that vitamin E levels are maintained within a narrow range.
Key Genes Involved in GO:0052871 alpha-tocopherol omega-hydroxylase activity
The following genes and proteins are directly involved in alpha-tocopherol omega-hydroxylase activity or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP4F2 | Primary enzyme catalyzing omega-hydroxylation of alpha-tocopherol in humans | Target for studying vitamin E metabolism and genetic variants affecting activity |
| CYP4F3 | Cytochrome P450 enzyme with overlapping substrate specificity | Potential compensatory role in vitamin E catabolism |
| CYP3A4 | Cytochrome P450 involved in drug metabolism, may contribute to vitamin E oxidation | Investigated for cross-talk with vitamin E metabolism |
| POR | Cytochrome P450 oxidoreductase, transfers electrons from NADPH to CYP enzymes | Essential cofactor for enzyme activity; knockout models affect vitamin E status |
| TTPA | Alpha-tocopherol transfer protein, regulates vitamin E distribution | Indirectly influences substrate availability for omega-hydroxylase |
| SCARB1 | Scavenger receptor class B member 1, involved in vitamin E uptake | Affects cellular alpha-tocopherol levels and subsequent catabolism |
| ABCB1 | ATP-binding cassette subfamily B member 1, transporter of vitamin E | Modulates intracellular concentrations of alpha-tocopherol |
| CYP4F2*3 | Common variant (rs2108622) with reduced enzyme activity | Associated with altered vitamin E status and disease risk |
| NFE2L2 | Transcription factor regulating antioxidant response, may influence CYP expression | Potential regulator of omega-hydroxylase under oxidative stress |
| PPARA | Peroxisome proliferator-activated receptor alpha, regulates lipid metabolism | May affect expression of CYP4F enzymes |
| HNF4A | Hepatocyte nuclear factor 4 alpha, liver-enriched transcription factor | Regulates CYP4F2 expression in liver |
| CYP4F11 | Cytochrome P450 enzyme with omega-hydroxylase activity toward various substrates | Potential alternative enzyme for vitamin E metabolism |
| CYP4F22 | Cytochrome P450 enzyme involved in lipid metabolism | May contribute to omega-oxidation of vitamin E |
| ALB | Albumin, transports vitamin E in plasma | Affects substrate delivery to liver for catabolism |
| APOA1 | Apolipoprotein A1, component of HDL, transports vitamin E | Influences vitamin E distribution and catabolism |
| CYP2C9 | Cytochrome P450 enzyme with broad substrate specificity | May oxidize vitamin E under certain conditions |
| CYP1A2 | Cytochrome P450 enzyme involved in xenobiotic metabolism | Potential role in vitamin E oxidation |
| NQO1 | NAD(P)H quinone dehydrogenase 1, antioxidant enzyme | May protect vitamin E from oxidation, indirectly affecting catabolism |
How Is alpha-tocopherol omega-hydroxylase activity Regulated?
Alpha-tocopherol omega-hydroxylase activity is regulated by substrate availability, enzyme expression, and genetic polymorphisms. Vitamin E intake can induce CYP4F2 expression, increasing catabolic capacity. The common CYP4F2 variant rs2108622 (CYP4F2*3) results in reduced enzyme activity, leading to higher plasma alpha-tocopherol levels. In nonalcoholic fatty liver disease, impaired cytochrome P450 function reduces alpha-tocopherol metabolism, contributing to altered vitamin E status. Additionally, transcription factors such as HNF4A and PPARA may regulate CYP4F2 expression in response to metabolic signals [7,8].
alpha-tocopherol omega-hydroxylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP4F2 | Nonalcoholic fatty liver disease, altered vitamin E metabolism | Liver-specific knockout or knock-in of CYP4F2*3 variant in mice |
| CYP4F2 | Cardiovascular disease, oxidative stress | Overexpression of human CYP4F2 in hepatocytes |
| TTPA | Vitamin E deficiency with ataxia | Ttpa knockout mice as model for vitamin E deficiency |
| POR | Impaired drug and vitamin E metabolism | Liver-specific Por knockout mice |
| NFE2L2 | Oxidative stress-related diseases | Nrf2 knockout mice to study regulation of CYP4F2 |
Nonalcoholic Fatty Liver Disease (NAFLD)
NAFLD is associated with impaired cytochrome P450-dependent metabolism of alpha-tocopherol. Studies show that in NAFLD, the activity of alpha-tocopherol omega-hydroxylase is reduced, leading to decreased formation of 13-hydroxy-alpha-tocopherol and altered vitamin E status. This impairment may contribute to oxidative stress and disease progression, suggesting that modulating this activity could be therapeutic.
Vitamin E Deficiency and Neurological Disorders
Genetic defects in alpha-tocopherol transfer protein (TTPA) cause vitamin E deficiency with neurological symptoms. While omega-hydroxylase activity is not directly mutated in these disorders, excessive catabolism due to high enzyme activity could exacerbate deficiency [1,8]. Understanding the balance between absorption, transport, and catabolism is crucial for managing these conditions.
Cardiovascular Disease and Oxidative Stress
Vitamin E metabolites generated by omega-hydroxylase activity, such as alpha-CEHC, have been shown to possess anti-inflammatory and antioxidant properties. Dysregulation of this pathway may influence cardiovascular risk by altering the balance of vitamin E and its metabolites. Genetic variants in CYP4F2 have been associated with altered vitamin E status, which may impact cardiovascular health.
From alpha-tocopherol omega-hydroxylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CYP4F2 knockout alter vitamin E status? | CYP4F2 knockout mice or HepG2 cells with CRISPR knockout |
| How does the CYP4F2*3 variant affect enzyme kinetics? | Knock-in of the variant in HEK293 cells or hepatocytes |
| Can we visualize CYP4F2 localization? | Knock-in of fluorescent tag (e.g., GFP) at the endogenous locus |
| What is the effect of CYP4F2 overexpression on vitamin E metabolites? | Adenoviral or lentiviral overexpression in primary hepatocytes |
| Which genes regulate CYP4F2 expression? | CRISPR activation (CRISPRa) library screening in liver cells |
| Does loss of CYP4F2 protect against NAFLD? | Liver-specific knockout in diet-induced obesity mouse model |
How to Study the alpha-tocopherol omega-hydroxylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | 13-hydroxy-alpha-tocopherol and other metabolites | Quantifying enzyme activity in cells or tissues |
| RNA-seq | CYP4F2 and related gene expression | Assessing transcriptional regulation |
| Western blot | CYP4F2 protein levels | Validating expression changes |
| CRISPR knockout | Loss-of-function of candidate genes | Determining causal role in vitamin E metabolism |
| CRISPR activation | Gain-of-function of endogenous genes | Identifying regulators of CYP4F2 |
| Recombinant enzyme assay | Kinetic parameters (Km, Vmax) | Characterizing variants |
| Immunofluorescence | Subcellular localization of CYP4F2 | Confirming endoplasmic reticulum localization |
| Metabolomics | Global vitamin E metabolite profile | Discovering novel metabolites |
Enzyme Activity Assays
Direct measurement of alpha-tocopherol omega-hydroxylase activity can be performed using liver microsomes or recombinant CYP4F2 expressed in insect cells or E. coli. The reaction is monitored by HPLC or LC-MS/MS quantification of 13-hydroxy-alpha-tocopherol formation [3,4]. These assays are essential for characterizing enzyme kinetics and the effects of genetic variants.
Gene Expression Analysis
RNA-seq and qPCR can quantify CYP4F2 and other cytochrome P450 transcripts in tissues or cell models. This helps assess how expression changes in response to vitamin E intake, disease states, or genetic perturbations [7,8]. Proteomics can complement by measuring protein levels.
Metabolomics and Lipidomics
LC-MS/MS-based metabolomics allows comprehensive profiling of vitamin E metabolites, including 13-hydroxy-alpha-tocopherol and alpha-CEHC, in biological samples. This is crucial for linking enzyme activity to physiological outcomes.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate CYP4F2 expression or vitamin E metabolism. For example, a CRISPRa screen in hepatocytes could uncover transcription factors that upregulate CYP4F2.
How CRISPR Can Be Used to Study GO:0052871 alpha-tocopherol omega-hydroxylase activity
Knockout
CRISPR knockout of CYP4F2 in liver cell lines (e.g., HepG2) or primary hepatocytes can abolish alpha-tocopherol omega-hydroxylase activity, leading to accumulation of alpha-tocopherol and reduced metabolite formation. This model is useful for studying the consequences of impaired vitamin E catabolism.
Point Mutation
Introducing the common CYP4F2*3 variant (rs2108622) via CRISPR point mutation allows investigation of its effect on enzyme activity and vitamin E status. This can be done in isogenic cell lines to control for genetic background.
Knock-in
Knock-in of a fluorescent tag (e.g., GFP) at the endogenous CYP4F2 locus enables real-time visualization of enzyme localization and dynamics in living cells. This approach can reveal how the enzyme traffics and interacts with partners.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of CYP4F2 can increase enzyme levels, enhancing alpha-tocopherol catabolism. This is useful for studying the effects of excess enzyme activity on vitamin E homeostasis and metabolite production.
How EDITGENE Supports alpha-tocopherol omega-hydroxylase activity Research
Researchers studying alpha-tocopherol omega-hydroxylase activity-related genes often need to determine whether a candidate gene is causally involved in vitamin E metabolism or disease. EDITGENE provides comprehensive CRISPR-based services to create precise cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for alpha-tocopherol omega-hydroxylase activity research.
Frequently Asked Questions About alpha-tocopherol omega-hydroxylase activity
What is alpha-tocopherol omega-hydroxylase activity?
It is the enzyme activity that catalyzes the first step in vitamin E catabolism, converting alpha-tocopherol to 13-hydroxy-alpha-tocopherol.
What genes are involved in alpha-tocopherol omega-hydroxylase activity?
The primary gene is CYP4F2, which encodes a cytochrome P450 enzyme. Other CYP4F family members may also contribute [3,5].
What is the GO ID for alpha-tocopherol omega-hydroxylase activity?
The Gene Ontology ID is GO:0052871.
How is alpha-tocopherol omega-hydroxylase activity regulated?
It is regulated by substrate availability, enzyme expression, and genetic variants such as CYP4F2*3 [5,7].
What diseases are associated with alpha-tocopherol omega-hydroxylase activity?
Nonalcoholic fatty liver disease and cardiovascular disease have been linked to altered activity [7,8].
What is the reaction catalyzed by alpha-tocopherol omega-hydroxylase?
It converts (+)-alpha-tocopherol to 13-hydroxy-alpha-tocopherol using oxygen and NADPH.
Which enzyme catalyzes alpha-tocopherol omega-hydroxylation in humans?
CYP4F2 is the major enzyme responsible for this activity in humans.
How can I study alpha-tocopherol omega-hydroxylase activity in the lab?
You can use LC-MS/MS to measure metabolite formation, or CRISPR knockout of CYP4F2 to assess loss of function [3,5].
What are the products of alpha-tocopherol omega-hydroxylase activity?
The primary product is 13-hydroxy-alpha-tocopherol, which can be further metabolized to alpha-CEHC.
Is alpha-tocopherol omega-hydroxylase activity conserved across species?
Yes, similar activity has been found in Drosophila and other species, indicating evolutionary conservation.
Conclusion
Alpha-tocopherol omega-hydroxylase activity (GO:0052871) is a key molecular function in vitamin E metabolism, responsible for initiating the catabolism of alpha-tocopherol. Its regulation by genetic and environmental factors influences vitamin E status and has implications for diseases such as NAFLD and cardiovascular disease. Continued research using CRISPR models will further elucidate its role and therapeutic potential.
References
- 1. Parker RS et al.. 2005. Selective accumulation of alpha-tocopherol in Drosophila is associated with cytochrome P450 tocopherol-omega-hydroxylase activity but not alpha-tocopherol transfer protein.. Biochem Biophys Res Commun 338(3):1537-41 PMID: 16289043
- 3. Sontag TJ et al.. 2002. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status.. J Biol Chem 277(28):25290-6 PMID: 11997390
- 4. Sontag TJ et al.. 2007. Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega-hydroxylase.. J Lipid Res 48(5):1090-8 PMID: 17284776
- 5. Bardowell SA et al.. 2010. Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity.. J Nutr 140(11):1901-6 PMID: 20861217
- 6. Parker RS et al.. 2004. Discovery, characterization, and significance of the cytochrome P450 omega-hydroxylase pathway of vitamin E catabolism.. Ann N Y Acad Sci 1031:13-21 PMID: 15753130
- 7. Bartolini D et al.. 2017. Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E).. J Nutr Biochem 47:120-131 PMID: 28628909
- 8. Jiang Q. 2022. Metabolism of natural forms of vitamin E and biological actions of vitamin E metabolites.. Free Radic Biol Med 179:375-387 PMID: 34785321
